{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T19:36:07Z","timestamp":1726428967147},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\nIntroduction While the current nomenclature of psychotropic drugs is disease-based, their approved indications do not always match their classifications.<\/jats:p><jats:p>\nMethods Information on approved indications of \u201csecond-generation antipsychotics\u201d and \u201cnewer antidepressants\u201d that are available in the United States (US), the United Kingdom (UK), France, Germany, and Japan were extracted from their packet inserts.<\/jats:p><jats:p>\nResults A significant proportion of \u201catypical antipsychotics\u201d were approved for psychiatric conditions other than psychotic disorders (i.\u2009e., bipolar disorder, major depressive disorder, and autistic disorder) as follows: 76.9% in the US, 66.7% in the UK, 66.7% in France, 60.0% in Germany, and 44.4% in Japan. Likewise, more than half of \u201cnewer antidepressants\u201d had approved indications for psychiatric conditions other than depression (e.\u2009g., panic disorder, obsessive compulsive disorder, social anxiety disorder, general anxiety disorder, and post-traumatic stress disorder): 56.3% in the US, 69.2% in the UK, 69.2% in France, 50.0% in Germany, and 62.5% in Japan.<\/jats:p><jats:p>\nConclusions Our results raise concerns regarding generic terminologies of \u201cantipsychotics\u201d and \u201cantidepressants\u201d since the conventional indication-based nomenclature does not fit well with the official indication.<\/jats:p>","DOI":"10.1055\/a-0626-7135","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T18:47:31Z","timestamp":1527101251000},"page":"175-179","source":"Crossref","is-referenced-by-count":1,"title":["Discrepancies Between Nomenclature and Indications of Psychotropics"],"prefix":"10.1055","volume":"52","author":[{"given":"Fusaka","family":"Minami","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Zohar","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Sheba Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry and Clinical Ethics, University of Yamanashi, Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruki","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gohei","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"},{"name":"Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2018,5,23]]},"container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-0626-7135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T18:41:19Z","timestamp":1562611279000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-0626-7135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":0,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2019,7,8]]},"published-print":{"date-parts":[[2019,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-0626-7135","relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"type":"print","value":"0176-3679"},{"type":"electronic","value":"1439-0795"}],"subject":[],"published":{"date-parts":[[2018,5,23]]}}}